Skip to main content
Log in

Is clinicopathological distinction of mucosa-associated lymphoid tissue lymphoma from Waldenström macroglobulinemia essential in MYD88 L265P mutation-positive cases?

  • Images in Hematology
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Acknowledgements

We gratefully acknowledge Dr. Shinichiro Okamoto of Division of Hematology, Department of Medicine, Keio University School of Medicine, for providing useful suggestions. This work was supported in part by a grant from the Japan Leukemia Research Fund (to K.K.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kensuke Kojima.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Informed consent

Written informed consent was obtained from the patients for publication.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kidoguchi, K., Kojima, K., Seki, R. et al. Is clinicopathological distinction of mucosa-associated lymphoid tissue lymphoma from Waldenström macroglobulinemia essential in MYD88 L265P mutation-positive cases?. Int J Hematol 109, 247–248 (2019). https://doi.org/10.1007/s12185-018-02585-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-018-02585-8

Navigation